To test the utility of green fluorescent protein (GFP) as an in vivo reporter protein when fused to a membrane domain, we made a fusion protein between yeast hydroxymethylglutaryl-CoA reductase and GFP. Fusion proteins displayed spatial localization and regulated degradation consistent with the native hydroxymethylglutaryl-CoA reductase proteins. Thus, GFP should be useful in the study of both membrane protein localization and protein degradation in vivo.
pRH408, with an in-frame fusion of the GFP coding region to nt 2106 (numbered from the start codon) of HMG1. The predicted fusion proteins have N-terminal transmembrane regions up to or fused to either seven or six, respectively, polylinker-encoded amino acids and then to GFP.
Yeast Strains and Growth. Yeast strain RWY60 (his3A200 lys2-801 ade2-101 ura3-52 met pep4::hisG) was transformed with HMG-R::GFP expression vector pRH407 (HMG1::GFP) or pRH408 (HMG2::GFP) as described (7). Each plasmid was introduced into the recipient strain by targeted integration at the Stu I site of the ura3-52 allele. The resultant strains were named RHY404 (RWY60 with GPDp-HMG1::GFP integrated at URA3), RHY405 (same as RHY404 but with a double integrant, as confirmed by DNA blotting) and RHY406 (RWY60 with GPDp-HMG2::GFP integrated at URA3). The average fluorescence of the HMG1::GFP double integrant (as measured by flow cytometry) was similar to that of the average fluorescence of the HMG2::GFP single integrant.
Strains expressing the authentic HMG2 (RHY183) or HMG1 (RHY105-25) coding regions integrated into the genome and driven by the GPD promoter were constructed as described (8). The above two strains were used for the comparison of the GFP fusion-expressing strains with those expressing the native proteins in the electron microscopic studies of Fig. 4 . Strain RHY420 (used in Fig. 5 A, B, and D) expressed the GPD-promoter driven HMG2 gene from a plasmid integrated at the URA3 locus as the only source of HMG-R activity and had a disruption of the PEP4 gene.
Optical Methods. Microscopy was performed on a Nikon Optiphot microscope with epifluorescence illumination. GFP fluorescence was observed in living cells with a Nikon DM510 filter for fluorescein fluorescence with illumination at 390 nm and long-bandpass emission. 4'-6-diamidino-2-phenylindole (DAPI) fluorescence (for DNA) was observed with a Nikon DM400 filter with illumination at 365 nm and emission at >400 nm. In vivo DAPI staining was done by adding DAPI (final concentration of 1 jig/ml) to the growing cultures of cells 3 h prior to examination and then washing the cells extensively prior to examination. Fields were photographed with Kodak Ektachrome P1600 color reversal film and transferred to CD Image Process color labs (Berkeley, CA). Confocal laser scanning microscopy and R6 fluorochrome staining (Fig. 3) were performed by using equipment and parameters identical to those described (8, 9). The digitized images from the fluorescent and confocal experiments were prepared as graphics by using Adobe Photoshop ver 2.5.1 and Canvas ver 3.5 and Abbreviations: GFP, green fluorescent protein; ER, endoplasmic reticulum; HMG-R, hydroxymethylglutaryl-CoA reductase; DAPI, 4'-6-diamidino-2-phenylindole; GPD, glucose-6-phosphate dehydrogenase; lOop6-7 antigen, lumenal loop of Hmg2p between the putative 6th and 7th transmembrane regions.
tTo whom reprint requests should be sent at present address: Department of Biology, University of California, San Diego, #0116, 9500 Gilman Drive, La Jolla CA, 92093-0116. Electron Microscopy. Cells were grown to log phase (1 OD600/ml) in YM glucose medium supplemented with the appropriate amino acids and 2% casamino acids and prepared for electron microscopy as previously described (10) with some modifications. Specifically, 40 ml of the culture was rapidly fixed with 10 ml of 5x phosphate-buffered fixative [lx = 137 mM NaCl/2.7 mM KCI/1.5 mM KH2PO4/6.5 mM Na2HPO4/1 mM CaCl2/1 mM MgCl2/2% (vol/vol) glutaraldehyde, pH 7.4] for 5 min at room temperature. Cells were pelleted briefly, resuspended in 1 x fixative, and fixed overnight at 4°C. After four washes with distilled water, cells were resuspended in 2 ml of distilled water and, 2 ml of 4% (wt/vol) potassium permanganate was added. After 5 min at room temperature, the cells were pelleted and incubated with 6 ml of fresh 2% (wt/vol) potassium permanganate for 1 h at room temperature. Finally, cells were stained en bloc with 1% uranyl acetate, dehydrated in a graded ethanol series, embedded in Pelco Ultra Low Viscosity Resin (Ted Pella, Redding, CA), sectioned, and stained as described (10).
Biochemical Analysis of Protein Stability. The half-life of the fusion protein was compared with that of native Hmg2p by analyzing immunoblots after protein synthesis was inhibited with cycloheximide at various times, as described (8). Regulated degradation of the Hmg2p-GFP fusion protein in living cells was studied by allowing cells to grow to stationary phase. Upon reaching stationary phase, Hmg2p continues to be degraded after cessation of protein synthesis, resulting in a drastically lowered immunoblotting signal when compared with the steady-state levels in logarithmic phase. The cells were grown in supplemented YM medium to late logarithmic phase (OD600 0.9). Aliquots from this stock were separated and, where indicated, were treated with lovastatin (final concentration of 25 ,ug/ml). At the same time, a fresh culture was inoculated at low density from the stock to provide a logarithmic-phase sample of cells at the end of the experiment. Cells were then allowed to resume growth at 30°C for 18 h, at which time equal numbers of cells were harvested and subjected to immunoblotting analysis as described (8).
Hmg2p and Hmg2p-GFP fusion protein were detected on immunoblots by using a polyclonal antibody raised against a fusion protein between the maltose binding protein (MBP) and the lumenal loop of Hmg2p between the putative 6th and 7th transmembrane regions (l0Op6-7 antigen). The loop6-7 antigen was made by PCR amplification of the region of the HMG2 gene encoding the loop, in-frame fusion of the PCR product to the MBP coding region of the pMal vector (New England Biolabs, MA), and purification of the plasmid-expressed MBP-HMG2 l0OP6-7 antigen fusion protein, as per the manufacturer's instructions.
RESULTS AND DISCUSSION
Distribution of HmgRp-GFP in Living Yeast. Strains expressing either the Hmglp-GFP ( Fig. 2A) or the Hmg2p-GFP (Fig. 2B) fusions (RHY405 or RHY406, respectively), were examined by fluorescence microscopy. The nuclear DNA was stained in vivo with DAPI (1 ,ug/ml). Comparison of the fluorescence from the GFP fusion (Fig. 2 Left) with that from the DAPI-stained nuclear DNA (Fig. 2 Right) showed that both proteins were localized in the nuclear envelope, as expected (red arrows). This pattern is especially prevalent in the Hmglp-GFP-expressing cells. In addition to the perinu- clear staining, cells expressing the Hmglp-GFP fusion show a reticular fluorescence pattern in the cytoplasm and cell periphery which is typical of ER-localized proteins in yeast (11, 12) . The Hmg2p-GFP fusion was present in one or more patches at the cell periphery or near the nucleus (white arrow).
In this figure, the Hmglp-GFP-expressing strain (RHY405) had a double integrant of the expression plasmid and thus exhibited more intense fluorescence than the same strain with a single integration. However, the distribution of Hmglp-GFP fluorescence in the single-integrant strain (RHY404) was identical to the distribution in the double integrant (data not shown). The double integrant of the HMGJ::GFP reporter was used in this comparison because the level of fluorescence between this strain and that of the HMG2::GFP single integrant was almost identical as measured by flow cytometry (data not shown).
Laser scanning confocal microscopy (Fig. 3A) demonstrated that Hmg2p-GFP was also distributed in the cell in a manner consistent with the characteristic ER localization, such that each cell had light perinuclear fluorescence (solid arrow) as S well as peripheral staining (open arrow). As in the lower resolution images shown in Fig. 2B , bright patches of staining were also visible, either associated with the perinuclear ring or separate from it.
Hmg2-GFP and Membrane Proliferations. The bright patches of staining seen at the light microscopic level appeared to be sites of proliferation of the ER membrane, similar to those described (4). To test this idea, we examined the cells with two additional methods: in vivo fluorescent dye staining and electron microscopy.
The strain expressing the Hmg2-GFP fusion (RHY406) was stained with R6 (red fluorescence), which labels areas of membrane proliferation (8, 9), and the cells were examined by confocal microscopy at filter settings for either GFP fluorescence (Fig. 3B Upper) or R6 fluorescence (Fig. 3B Lower) . In all cells examined, the GFP staining overlapped with the R6 staining, indicating that the structures that contained Hmg2p-GFP had the biophysical properties of membranes undergoing proliferation. GFP alone did not give a signal with the R6 settings. We next examined the ultrastructure of isogenic strains expressing either native Hmg2p (Fig. 4 A and C) or Hmg2p-GFP (Fig. 4 B and D) from identical promoters. In both strains, the predominant structures were strips of stacked membranes (Fig. 4 A and B) , sometimes along the nuclear border, and concentric whorls of membrane separate from the nucleus (Fig. 4 C and D) . Although the distance between the membrane layers in the Hmg2p-GFP-expressing strain appeared to be greater than those induced by native Hmg2p, the fusion protein caused the same types of proliferated structures as the native protein, and these structures were consistent with those visible in vivo by fluorescence microscopy.
In these strains, the expression of neither Hmglp-GFP nor the native Hmglp caused proliferations. This result was surprising since high levels of Hmglp expression are known to induce karmellae (4). However, they demonstrated that the GFP fluorescence faithfully reported proliferations when and only when they were present.
Degradation of the Hmg2-GFP Fusion Protein. The Hmg2p protein is subject to regulated degradation at or in the ER itself (7). As in mammalian cells, the degradation of Hmg2p is regulated by the mevalonate pathway, such that high pathway flux causes a high degradation rate, and low flux causes a low (5-7) . The degradation of both Hmg2p-GFP and authentic Hmg2p was studied by using an antibody that recognizes a common Hmg2p-specific region, the lumenal loop between transmembrane domains 6 and 7 (Fig. 5A) .
When a logarithmic-phase strain expressing the Hmg2p protein from the GPD promoter (RHY420) was grown to stationary phase, the degradation of Hmg2p continued after protein synthesis ceases, and the total Hmg2p immunoreac-A S L., C 0c -tivity declined drastically (Fig. 5A, lanes marked Hmg2p) . The lane labeled log measured the steady-state amount of Hmg2p in a logarithmic-phase culture. When cultures were allowed to grow to stationary phase without lovastatin the amount of Hmg2p was much lower. If the mevalonate pathway were slowed by the inclusion of a small dose of lovastatin in the cultures during growth into stationary phase, the expected slowing of Hmg2p degradation occurred, and the loss of total immunoreactivity was prevented. The stable Hmglp protein is not lost upon growth into stationary phase (data not shown). Thus, as in the other assays of Hmg2p regulated degradation (8), the loss of Hmg2p by growth into stationary phase was specific for the rapidly degraded isozyme and was regulated by the mevalonate pathway. The Hmg2p-GFP fusion protein also showed regulated degradation like the parent Hmg2p isozyme (Fig. 5A, lanes marked Hmg2p-GFP) .
The fluorescence of the Hmg2p-GFP fusion was also subjected to regulated degradation, as measured by flow cytometry ( Fig. 5B ) and by examination of the cells by fluorescence microscopy (Fig. 5D ). In this experiment, cells expressing the Hmg2p-GFP fusion were grown to stationary phase in the presence or absence of 25 ,ug of lovastatin per ml and examined by each technique. A non-GFP-expressing control was included in the histograms.
Both Hmg2p-GP and the Hmg2p were degraded at similar rates, with half-lives on the order of 1.5 h under these conditions. This was determined by inhibiting protein synthesis with cycloheximide and immunoblotting at various times (Fig.  SD) . The loss of Hmg2p-GFP was prevented by addition of lovastatin (25 p,g/ml) to a sample of the cycloheximide-treated culture at the beginning of the experiment. Taken together, these studies indicate that GFP will be a useful reporter for studying processive protein degradation as well as localization.
